Evidence map›Paper›PMID 42278842›Full record

ArticleHealthcare (Basel, Switzerland)2026

Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy.

Elise C Tarbi, Ian Bhatia, Nabil Balach, Suzannah Buehler, Magdalena Demeo-Meres, Cailin Gramling, Tej Thambi, Julia Hart, Maija Reblin, Donna M Rizzo and 3 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Elise C TarbiDepartment of Nursing, University of Vermont, Burlington, VT 05405, USA.ORCID 0000-0003-2452-6632
Ian BhatiaDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Nabil BalachDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Suzannah BuehlerDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Magdalena Demeo-MeresDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Cailin GramlingDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Tej ThambiCollege of Letters and Science, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Julia HartDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Maija ReblinDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.ORCID 0000-0003-3108-465X
Donna M RizzoDepartment of Civil & Environmental Engineering, University of Vermont, Burlington, VT 05405, USA.ORCID 0000-0003-4123-5028
Robert GramlingDepartment of Family Medicine, Vermont Conversation Lab, University of Vermont, Burlington, VT 05405, USA.
Manish AgrawalSunstone Therapies, Rockville, MD 20850, USA.
Emily ManettaLinguistics Program, University of South Carolina, Columbia, SC 29208, USA.ORCID 0000-0003-0291-3500

Funding

U.S. National Science Foundation 2242829
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aweinterpersonal communicationpsilocybinpsychedelic-assisted therapypsychedelics

Identifiers

PMID42278842
PMCPMC13256779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.